AIM

AIM ImmunoTech Inc. AIM

AIM
AIM ImmunoTech Inc. QNNTF
Quantum Genomics S.A. KTTA
Pasithea Therapeutics Corp. CHMMF
Chimeric Therapeutics Limited LIANY
LianBio OGEN
Oragenics, Inc. TOVX
Theriva Biologics, Inc. IBO
Impact BioMedical Inc. CERO
CERo Therapeutics Holdings, Inc. PCSA
Processa Pharmaceuticals, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AIM QNNTF KTTA CHMMF LIANY OGEN TOVX IBO CERO PCSA
6M -14.00 % 0.00 % -47.59 % 0.00 % -64.45 % -77.49 % -60.68 % 23.21 % -76.21 % 77.29 %
YTD -88.27 % 0.00 % -74.60 % 0.00 % -74.09 % -88.06 % -72.83 % -60.39 % -97.27 % -51.00 %
1Y -90.08 % 0.00 % -84.27 % 0.00 % -76.30 % -86.35 % -67.75 % -51.20 % -98.31 % -64.43 %
3Y -94.63 % -97.06 % -97.02 % -98.46 % -95.98 % -99.69 % -98.26 % -99.84 % -99.98 % -98.90 %
5Y -98.91 % -98.20 % -98.95 % -98.46 % -99.48 % -99.88 % -99.45 % -99.84 % -99.98 % -99.52 %
10Y -99.97 % -98.20 % -98.95 % -98.46 % -99.48 % -99.99 % -100.00 % -97.56 % -99.98 % -99.47 %
From the beginning -71.86 % -98.20 % -98.95 % -98.46 % -99.48 % -100.00 % -100.00 % -97.56 % -99.98 % -99.87 %

Dividend

LianBio